Kalimutho, Murugan Sinha, Debottam Mittal, Deepak Srihari, Sriganesh Nanayakkara, Devathri Shafique, Shagufta Raninga, Prahlad Nag, Purba Parsons, Kate Khanna, Kum Additional file 2: of Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT signaling in breast cancer using TCGA dataset. (B, C) A combined panel of selected breast cancer and near-normal cell lines was reverse-transfected with 10 nM pooled JAK1, JAK2, STAT3 or KRAS siRNAs and cell viability determined after 6 days. Cell viability relative to its own respective control transfected with scramble siRNA was calculated, n = 2–3 (*p < 0.05, p < 0.01). Individual cell lines are shown in panel C. (JPG 2069 kb) TNBC;PDGFRβ;JAK2;Resistance;CD8+ T cell 2019-02-18
    https://springernature.figshare.com/articles/figure/Additional_file_2_of_Blockade_of_PDGFR_circumvents_resistance_to_MEK-JAK_inhibition_via_intratumoral_CD8_T-cells_infiltration_in_triple-negative_breast_cancer/7734698
10.6084/m9.figshare.7734698.v1